EDGAR Filing Documents for 0001104659-20-024477

Form 8-K - Current report:

SEC Accession No. 0001104659-20-024477

Filing Date

2020-02-25

Accepted

2020-02-25 07:47:08

Documents

Period of Report

2020-02-25

Items

Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2010874d2_8k.htm	8-K	19062
2	EXHIBIT 99.1	tm2010874d2_ex99-1.htm	EX-99.1	176495
3	GRAPHIC	tm2010874d2_ex99-1img02.jpg	GRAPHIC	10366
	Complete submission text file	0001104659-20-024477.txt		211225

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053

Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200

Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 8-K | Act: 34 | File No.: 001-37569 | Film No.: 20647375
SIC: 2834 Pharmaceutical Preparations